Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial
Jeffrey L. Bennett(University of Colorado Denver), Bruce Cree(University of California, San Francisco), Eliezer Katz, William A. Rees(Mayo Clinic), Gary Cutter(Epilepsy Foundation), Brian G. Weinshenker(Mayo Clinic in Arizona), Orhan Aktaş(Heinrich Heine University Düsseldorf), Friedemann Paul(Max Delbrück Center), Hans‐Peter Hartung(The University of Sydney), Kazuo Fujihara(Tohoku University), Michele Gunsior(Integrated BioTherapeutics (United States)), Sean J. Pittock(Mayo Clinic), Romain Marignier(Hospices Civils de Lyon), Michael Levy(Mass General Brigham), Ho Jin Kim(National Cancer Center), Yan Li(China Medical University), Michael Smith(Amgen (United States)), Dewei She, Dean M. Wingerchuk(WinnMed), Daniel Cimbora, Ari Green(University of California, San Francisco)
Cited by 42
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k